Literature DB >> 25977147

Remission of splenic marginal zone lymphoma in a patient treated for hepatitis B: a case of HBV-associated lymphoma.

A W A Koot, A P Visscher, R M H G Huits.   

Abstract

Splenomegaly is a common finding in chronic hepatitis B infection. We present the case of a man with an acute flare of chronic hepatitis B infection, where splenomegaly in absence of portal hypertension led to the diagnosis of splenic marginal zone lymphoma (SMZL) with bone marrow involvement. Adequate suppression of the hepatitis B virus (HBV) viral load with tenofovir resulted in complete remission of the lymphoma.

Entities:  

Keywords:  Antiviral therapy,; B-cell non-Hodgkin lymphoma; Chronic hepatitis B,; SMZL,; Splenic marginal zone lymphoma,

Mesh：

Substances：

Year:  2015        PMID： 25977147     DOI： 10.1179/2295333715Y.0000000005

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN： 1784-3286            Impact factor:   1.264


  5 in total

1.  High prevalence of viral hepatitis in a series of splenic marginal zone lymphomas from Romania.

Authors:  B Fetica; B Pop; M L Blaga; A Fulop; D Dima; M T Zdrenghea; C I Vlad; A S Bojan; P Achimas-Cadariu; C I Lisencu; A Irimie; D D Weisenburger
Journal:  Blood Cancer J       Date:  2016-11-11       Impact factor: 11.037

2.  Prevalence of hepatitis B and hepatitis C viral infections in various subtypes of B-cell non-Hodgkin lymphoma: confirmation of the association with splenic marginal zone lymphoma.

Authors:  W Xiong; R Lv; H Li; Z Li; H Wang; W Liu; D Zou; L Qiu; S Yi
Journal:  Blood Cancer J       Date:  2017-03-31       Impact factor: 11.037

3.  Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

Authors:  Müfide Okay; Tuncay Aslan; Evren Özdemir; Ayşegül Üner; Arzu Sağlam; Elif Güngör; Ayşe Uysal; Nevin Alayvaz Aslan; Esra Yıldızhan; Abdullah Ağıt; Mehmet Sinan Dal; Serdal Korkmaz; Sinem Namdaroğlu; Serdar Sivgin; Gülsüm Akgün Çağlıyan; Sinan Demircioğlu; İbrahim Barışta; Esra Özhamam; Filiz Vural; Bülent Eser; Gülsüm Özet; Rahşan Yıldırım; Mehmet Hilmi Doğu; İlhami Berber; Mehmet Ali Erkurt; Ümit Yavuz Malkan; Fevzi Altuntaş; Yahya Büyükaşık
Journal:  Turk J Haematol       Date:  2019-10-21       Impact factor: 1.831

4.  Establishment and characterization of HBV-associated B lymphocytes with an immortalization potential.

Authors:  Xiaoying Qi; Xien Gui; Ke Zhuang
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

5.  Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.

Authors:  Luís Alberto de Pádua Covas Lage; Felipe Faganelli Caboclo Dos Santos; Débora Levy; Frederico Rafael Moreira; Samuel Campanelli Freitas Couto; Hebert Fabrício Culler; Renata de Oliveira Costa; Vanderson Rocha; Juliana Pereira
Journal:  BMC Cancer       Date:  2020-08-03       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.